Page 3 - Purchase Common News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Purchase Common. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Purchase Common Today - Breaking & Trending Today

Filing Details - Insider Monkey

Published: December 16, 2022

Filing Details

Source: insidermonkey.com

Related Topics:

Co Aquabounty Technologies IncRemaning HoldingsAquabounty Technologies IncHunting And TrappingMain PlacePurchase CommonAquabounty TechnologiesIncentive Plan

Filing Details - Insider Monkey

Published: December 16, 2022

Filing Details

Source: insidermonkey.com

Related Topics:

Co Aquabounty Technologies IncRemaning HoldingsAquabounty Technologies IncHunting And TrappingMain PlacePurchase CommonAquabounty TechnologiesIncentive Plan

Filing Details - Insider Monkey

Published: August 18, 2022

Filing Details

Source: insidermonkey.com

Related Topics:

Remaning HoldingsTribology CenterPurchase CommonCommon Stock

Filing Details - Insider Monkey

Published: July 14, 2022

Filing Details

Source: insidermonkey.com

Related Topics:

Exchange CommissionInnoviva Merger Sub IncInnoviva IncRemaning HoldingsEntasis Therapeutics Holdings IncInnoviva Strategic OpportunitiesBayshore Highway SuitePurchase CommonInnoviva Merger SubEntasis Therapeutics HoldingsMerger AgreementMerger SubSecurities Purchase AgreementNote PurchaseConvertible Note

Leap Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results

Published: March 11, 2022

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported...

Source: prnewswire.com

Related Topics:

United KingdomNew ZealandMatthew DeyoungLeica BiosystemsDouglase OnsiBeigene LtdPartnership On CompanionPrnewswire Leap Therapeutics IncSecurities ExchangeLeap Therapeutics IncSociety Of Gynecologic OncologyDistinguish StudyGynecologic OncologyChief Executive OfficerPublic OfferingCommon StockPre Funded WarrantsPurchase CommonCompanion DiagnosticAdvance CareStaining SystemNew DataDistinguish Clinical TrialLine PartKey Findings